We evaluated the discrepancy of endophenotypic performance between probands with schizophrenia and unaffected siblings by paternal age at proband birth, a possible marker for de novo mutations. Pairs of schizophrenia probands and unaffected siblings (N¼ 220 pairs) were evaluated on 11 neuropsychological or neurophysiological endophenotypes previously identified as heritable. For each endophenotype, the sibling-minus-proband differences were transformed to standardized scores. Then for each pair, the average discrepancy was calculated from its standardized scores. We tested the hypothesis that the discrepancy is associated with paternal age, controlling for the number of endophenotypes shared between proband and his or her sibling, and proband age, which were both associated with paternal age. The non-significant association between the discrepancy and paternal age was in the opposite direction from the hypothesis. Of the 11 endophenotypes only sensori-motor dexterity was significant, but in the opposite direction. Eight other endophenotypes were also in the opposite direction, but not significant. The results did not support the hypothesized association of increased differences between sibling/ proband pairs with greater paternal age. A possible explanation is that the identification of heritable endophenotypes was based on samples for which schizophrenia was attributable to inherited rather than de novo/non-inherited causes.
Introduction
Genetic factors have long been implicated in schizophrenia, but identifying specific genetic causes has been difficult; it is highly likely that multiple genes of modest effect are involved, but rare de novo (i.e. non-familial) genetic variants also appear to have key roles in some cases (Gejman et al., 2011) . For genetic studies seeking to isolate specific genes related to schizophrenia liability, it would be useful to identify characteristics that might separate cases with primarily familial variants from those with de novo genetic mutations.
Previous studies observed the following generalities: (a) Increased age is associated with a higher rate of de novo mutations and other genomic abnormalities in male germ cells (Crosnoe and Kim, 2013; Singh et al., 2003) ; (b) Such abnormalities are more common in schizophrenia than in normal controls (Walsh et al., 2008) ; and, (c) Older paternal age is associated with greater risk of schizophrenia (Malaspina, 2001) . A model that explains how (a) and (b) could imply (c) is that de novo mutations and other genomic abnormalities are more frequently among the contributing factors leading to schizophrenia when the proband has an older father versus a younger one (Kong et al., 2012) . It is further supported by a report that schizophrenia patients without a family history of schizophrenia have significantly older fathers than those with such a history (Malaspina et al., 2002) . In this model, the proportion of schizophrenia attributable to de novo mutations is larger when the father is older. Conversely, inherited schizophrenia and its associated characteristics will be less common as the father's age increases. Although each piece of the model has been tested, the full model has not been directly tested. The present study was designed to test whether the age of the father at the birth of a schizophrenia proband -called "paternal age" -might be useful in this way for genetic studies of schizophrenia endophenotypes.
An endophenotype is a heritable characteristic associated with a disorder of interest that may be more strongly associated with some liability genes than others. Using endophenotypes may thus reduce genetic complexity, compared with the disorder itself (Gottesman and Gould, 2003) , although some traits may possess their own complexity. A defining characteristic of an endophenotypic deficit is that -compared with the general population -not only will it be more prevalent in those with the disorder, but also in their relatives without the disorder, albeit perhaps smaller (Gottesman and Gould, 2003) . Heritability implies that measures of endophenotypes will tend to be more similar between probands and their siblings than either would be with unrelated unaffected individuals. In contrast, when the genetic component of the disease is primarily caused by de novo genetic mutations, probands and their unaffected siblings, who are not monozygotic twins, would have more discrepant measures of endophenotypes.
We hypothesized that the endophenotypic discrepancy would increase as paternal age increased. To test this hypothesis, we used the Consortium on the Genetics of Schizophrenia (COGS) family database of schizophrenia proband families with one unaffected sibling (called here "sibling/proband pairs"). From a battery of psychophysiological and neuropsychological endophenotypes, we selected the 11 previously identified in a family-based study as heritable . For each sibling/proband pair, we summarized the differences in scores on those endophenotypes that were measured on both members of the pair, and tested whether in fact endophenotypic discrepancies increased as paternal age increased.
Methods

Subjects
Subjects were participants in the COGS-I, a multi-site family-based study of the genetics of neuro-cognitive and neurophysiological endophenotypes associated with schizophrenia. Full details of the COGS-I recruitment and assessment procedures are reported elsewhere and included standardized clinical assessment interviews of all subjects. All participants who are endophenotyped were between the ages of 18-65 and able to understand and provide informed consent. Consenting parents older than 65 had their blood drawn for genotyping purposes but did not undergo endophenotyping. The core family structure for COGS-I required at least one sibling/proband pair, i.e., the presence of a proband with schizophrenia and at least one unaffected full sibling. The probands were required to meet criteria for DSM-IV schizophrenia, following a standardized clinical assessment, medical record review, and best estimate diagnostic evaluation. Unaffected siblings never met criteria for any psychotic disorder, major affective disorder, or schizotypal personality disorder by the same clinical assessment. Subjects were screened for illicit drug or alcohol use at the time of testing and excluded if they tested positive. Also excluded were subjects who met criteria for a substance abuse disorder in the past month or a substance dependence disorder in the past 6 months. In the present study, a sibling/proband pair from each family was identified from those for whom the paternal and maternal ages at birth of the proband were known. Interviewers and endophenotypers were not blind to diagnostic group, but blind to the hypothesis of the study. An endophenotype that was tested in both the sibling and the proband from the same family was called a "shared endophenotype." If there was more than one unaffected sibling, we used the one with the largest number -at least two -of shared endophenotypes (if tied, the oldest sibling).
Endophenotype assessment
From the COGS endophenotype assessment battery, we selected those among the primary measures previously identified as heritable in a family-based study , and described in detail elsewhere: 1) Antisaccade performance. In this test of oculomotor inhibition, participants are asked to fixate on a central target and respond to a peripheral cue by looking in the opposite direction at the same distance. The ratio of correct antisaccades to total interpretable saccades is measured . 2) Prepulse Inhibition of the startle response (PPI). Prepulse inhibition refers to the dampening of a response to a strong startling stimulus (pulse) when the stimulus is preceded by a weaker prestimulus (prepulse).This was measured as the percentage of inhibition of the startle reflex in response to a weak pre-stimulus using a 60-ms interstimulus interval (Braff et al., 1978; Braff et al., 2001 ).
3) Continuous Performance Test (CPT). The Degraded Stimulus version of the CPT
(DS-CPT) is a widely used measure of deficits in sustained, focused attention with a high perceptual load. Participants detect a blurred target digit in a series of blurred other digits. DS-CPT performance was measured using the signal/ noise discrimination index (d 0 ) (Nuechterlein and Asarnow, 1999; Nuechterlein et al., 1983) . 4) Letter-Number Span (LNS). This is a measure of working memory information storage with manipulation. It is measured as the correct reordering of intermixed numbers and letters (Horan et al., 2008; Gold et al., 1997; Lenzenweger and Gold, 2000) . 5) California Verbal Learning Test (CVLT). The CVLT is a list-learning test that assesses verbal learning and memory. The total recall score of a list of 16 verbally presented items summed across five trials is measured (Stone et al., 2011) . 6) Penn Computerized Neurocognitive Battery (CNB). The Penn CNB is a computerized neuropsychological test battery used to assess a range of neuropsychological functions (Gur et al., 2001b; Gur et al., 2001a) . Each test is measured as "efficiency," a combination of accuracy (percentage correct) and speed (median response time in milliseconds), which is calculated as accuracy/log 10 (speed) and is expressed as standard equivalents (z scores). In the COGS modification of the Penn CNB, the following six cognitive domains were found to be heritable in the earlier family-based study and thus included in the present study: a) abstraction and mental flexibility -four objects are presented on a computer screen and the participant must choose the one that does not belong; b) face memory -participants are asked to recognize 20 previously presented target faces among 20 distracter faces; c) spatial memory -identical format as face memory except that Euclidean shapes, rather than faces, are used; d) spatial processing -two lines are presented at an angle, and the corresponding lines must be identified on a simultaneously presented array; e) sensorimotor dexterity -the participant is asked to click as quickly as possible using the computer mouse on a target that gets increasingly smaller; and f) emotion processing -involves correctly identifying a variety of facial expressions of emotion.
Statistics
For each of the endophenotypes, it was hypothesized that the difference between the unaffected sibling and the proband would be larger for older paternal age. If we had complete data, the hypothesized relationships for each endophenotype could be tested by a repeated measures analysis of covariance, with the dependent variables being the sibling score minus the proband score in each family, with paternal age as the covariate. The tests for paternal age would be the association with the average across all the endophenotypes and the interaction of paternal age with the differences among the endophenotypes -i.e. the heterogeneity among the endophenotypes' associations with paternal age. However, in this dataset, only 80 families had proband/sibling pairs with all 11 endophenotypes of interest. If either the proband or the sibling is missing on any specific endophenotype, the requirement for complete data in a repeated measurements analysis excludes that pair from the entire analysis. Missing data would not preclude separate analyses for each endophenotype, on the available sibling/ proband pairs, using the Bonferroni inequality. However, this would penalize for performing 11 tests of significance, even when the results are consistent across endophenotypes.
Thus, rather than primarily focusing on single endophenotypes, we chose to focus on the sibling/proband pairs, evaluating each across the available endophenotypes. In an idealized outcome with no interaction, if all endophenotypes have the same mean and variance, each sibling/proband pair would have the same difference for all endophenotypes. Insofar as the endophenotypes have different units of measurement, differences for a pair on different endophenotypes would be numerically different although comparable. Therefore, for each endophenotype, we created standardized scores (mean¼ 0, standard deviation ¼ 1) from the sibling minus proband differences. Then for each sibling/proband pair, we evaluated the "average discrepancy" of the standardized differences on their shared endophenotypes, and used this as the unit of analysis. We calculated partial correlations between the average discrepancy and paternal age with relevant covariates added as described below.
We considered the following as potential covariates: the number of shared endophenotypes, sibling's and proband's ages and sexes; father's, mother's, and sibling's years of education; maternal age at proband's birth; paternal and maternal age at birth of the first unaffected sibling; proband age at onset; and multiplex vs. simplex family status. Of these, we included the variables that were significantly associated with average discrepancy in sibling/proband pairs for the shared endophenotypes. We did not consider proband's years of education, since it may be substantially associated with age at onset and the course of the disorder. An additional analysis evaluated the quadratic model for proband's paternal age, by testing the quadratic component.
Results
Of 274 proband families, 54 (19%) were missing either at least one paternal age (N ¼41) or at least two shared endophenotypes (N ¼ 11) or both (N ¼ 2). Standardized differences between shared endophenotypes were calculated from the remaining 220 families with sibling/proband pairs. The average number of shared endophenotypes was 9.3 72.3. Among the sibling/proband pairs, there were significant associations with the average discrepancy for the number of shared endophenotypes (r ¼ À0.323, p o0.0005) and proband age (r ¼0.179, p¼ 0.01), but not for the other potential covariates. Thus, in the analyses of the association of paternal age with average discrepancy and also the sibling/proband raw difference for each of the 11 endophenotypes, these two variables were used as covariates when we calculated the partial correlations. The Bonferroni adjustment for 11 endophenotypes was p ¼0.05/11 ¼0.0045. The motivation for focusing on the average discrepancy was to avoid this Bonferroni adjustment. Table 1 presents characteristics of the 220 sibling/probands pairs, for the probands, their selected siblings, and their parents.
Paternal age ranged from age 17-63 and, as expected, the distribution was somewhat skewed at the upper end (skewness ¼0.92), as there tend to be more older father exceptions than younger ones. After controlling for the two covariates, paternal age was not associated with the average discrepancy between siblings' and probands' endophenotype scores (partial r ¼ À0.094, d.f. ¼ 216, p ¼0.22). For exploratory purposes, we included the maternal age of the proband as an additional covariate and the results were not significant (partial r ¼ À0.030, d.f. ¼215, p ¼0.66). As shown in Table 2 , the only specific endophenotypes that even approached statistical significance (without the Bonferroni adjustment) were the cognitive domain score for sensorimotor dexterity (partial r ¼ À0.206, d.f. ¼185, p ¼0.0047) and abstraction and mental flexibility (partial r ¼ À0.123, d.f. ¼182, p¼ 0.097). The remaining partial correlations ranged from À 0.107 to.060. Although none of these other correlations were significant, we noted that a total of 9-11 were negative. The negative correlations indicated that the sibling/proband discrepancies were nominally smaller as paternal age increased, contrary to our hypothesis. There were no significant associations for the quadratic model (partial r¼ À0.044, d.f. ¼215, p ¼0.52).
Discussion
Excluding more likely de novo schizophrenia cases would enhance studies of inherited genetic variants, so we performed this study of schizophrenia endophenotypes to assess whether paternal age might serve as a proxy for de novo mutations. The results did not support the hypothesis that endophenotypic average discrepancies in sibling/proband pairs increases as paternal ages of probands with schizophrenia increases. For each sibling/proband pair, we summarized the average discrepancy of up to 11 primary endophenotypes in COGS previously found to be heritable among schizophrenia proband families . The relationship between paternal age and the summary was non-significant and in the direction opposite from the hypothesis. Additionally, when endophenotypes were examined individually, the only significant endophenotype -but not significant by the Bonferroni adjustment for 11 endophenotypeswas in the opposite direction from that hypothesized, as were eight of the other 10 endophenotype results.
In contrast to our model, paternal age may be a poor proxy for de novo mutations in schizophrenia. No study to our knowledge has specifically examined the effect of paternal age on the rate of de novo mutations in schizophrenia compared with the general population. It is possible that paternal age is a risk factor for schizophrenia more from underlying sociological causes than from biological or genomic ones. Paternal age might be a risk factor for schizophrenia because older fathers are more likely to have greater genetically mediated schizophrenia related personality traits, such as aloofness and inappropriate rapport (Kendler et al., 1995) . The presence of these traits might both indicate a greater genetic load and tend to delay mating in the social world. Matching the Danish national psychiatric registry with the Danish Civil Registry System, risk for schizophrenia was associated with late fatherhood (age at the birth of the first child), and controlling for this nullified the association of risk for schizophrenia with paternal age of the proband (Petersen et al., 2011) . This suggests that late fatherhood underlies the increased risk for schizophrenia observed with older paternal age. Consistent with this possibility, we cautiously note that for the individual endophenotypes most of the discrepancies were nominally reduced with increasing paternal age, which would be expected if older fathers were carrying a greater familial/genetic load.
However, two comparisons of probands with and without a family history for schizophrenia do not support this late fatherhood model. In the Danish study, risk for schizophrenia was similarly associated with later fatherhood in probands with and without a family history of schizophrenia (Petersen et al., 2011) . Contrary to the late fatherhood model, probands with a positive family history have been observed to have relatively younger fathers than probands without a family history (Malaspina et al., 2002) . It must be noted that in both of these studies, proband family history does not ensure paternal family history of schizophrenia which would be a basis for the late fatherhood model.
Our model assumed that the traits assessed were associated with schizophrenia, regardless of whether schizophrenia was attributable to inherited or de novo/non-inherited causes. An alternative endophenotypic model would explain the lack of significance by assuming that these traits are only found in the inherited form. In both the original and the alternative model, for inherited schizophrenia, siblings would average between unrelated, unaffected individuals and probands, since the sibling would tend to have an incomplete version of the genetic load of the proband. In the original model, for de novo schizophrenia, the sibling would not carry the deficit, and instead be like individuals in families without schizophrenia, very different from the proband. In the alternative model, both the de novo proband and the sibling would not have any inherited endophenotypic deficits, and thus the pair would not be substantially different from each other. In this regard, in a separate study from our consortium, the association between paternal age and the severity of endophenotypic performance was recently assessed in both primary and secondary endophenotypes (Tsuang et al., 2014) . Only one (of 16) endophenotypes was significantly associated with paternal age (a secondary endophenoytype in the COGS, the CPT-IP, and thus not included in this study and not previously included in our heritability study). The specific result indicated better performance was associated with older fathers, consistent with observed results in this study, contrary to the original hypothesis. However, this result did not remain significant after adjusting for sixteen comparisons.
Our sample was relatively large, but limited by having few probands with truly late paternal ages, for which the effect of paternal age is stronger . Of the 220 sibling/ proband pairs, only 21 had paternal ages at or beyond age 40. The dearth of older fathers might have been exacerbated by the ascertainment methods in the COGS-I family study, which focused on recruiting schizophrenia proband families with a minimum of two offspring and living parents who could be recruited for a blood draw and, if younger than age 65, endophenotypic testing. This recruitment goal might have reduced ascertainment of families with older fathers. Nevertheless, we do regard this group as constituting "older fathers" with respect to schizophrenia risk. A recent study of the Danish population found that, compared with rates for schizophrenia for offspring of fathers aged 25-29, the incidence rate ratios (IRR) for offspring of fathers at greater ages, categorized by five year intervals, were all significantly higher. The IRRs rose from 1.08 to 1.21 to 1.40, as paternal age groups increased from 30-34 to 35-39 to 40-44, but for fathers aged 45þ the IRR rose less, to 1.47 (McGrath et al., 2014) , despite the open age range.
Another limitation was that by using only one sibling/proband pair per family we avoided concerns about lack of independence between multiple pairs within the same family, but at the same time we did not exploit all the information in the family that might have been present in some of the families. Finally, in autism, another disorder in which paternal age has been found to be a risk fact (McGrath et al., 2014) , we note that the presence of a child with autism may lead a reduced number of subsequent children (stoppage rules), but the diagnosis of schizophrenia is usually substantially later. Nonetheless, if the first child has schizophrenia, there may be premorbid traits that could inhibit having additional children afterwards, which would make the family ineligible for our study.
To present descriptively the impact of proband age after age 40 on the average discrepancy, we created four categories, 34 and below (n¼ 165), 35-39 (n ¼34), 40-44 (n ¼13), and 45-63 (n ¼8). small sample sizes for probands over age 40, this result confirms the failure of the original hypothesis. Contrary to our hypothesis, we did not find that the average discrepancy between sibling and proband performance was associated with paternal age. Moreover, the only significant association among the 11 endophenotyes, and the majority of associations, were in the opposite direction. A possible explanation is that the endophenotypes included in this study were identified due to their relevance to genetically-transmitted schizophrenia, but they are not relevant to schizophrenia arising from de novo mutations.
